# Zhejiang Hisun Pharmaceutical

Source: https://onco.cc/companies/zhejiang-hisun/  
OnCo record `zhejiang-hisun` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Hisun is a large Chinese maker of active ingredients and generic injectables, founded in 1952 in Taizhou, whose biosimilar and generic cancer medicines go through the phase 3 trials it sponsors.

## Summary

Zhejiang Hisun Pharmaceutical, headquartered in Taizhou, Zhejiang, and listed in Shanghai, is one of China's largest producers of active pharmaceutical ingredients and sterile injectables, including anthracyclines and other cytotoxics, and has moved into biosimilars such as adalimumab and bevacizumab. ClinicalTrials.gov lists Hisun as lead sponsor of a phase 3 cancer trial.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: Zhejiang Hisun Pharmaceutical Co. Ltd.; Hisun; 浙江海正药业
- Tags: ctgov-sponsor
- HQ: Taizhou
- Type: pharma
- Website: http://www.hisunpharm.com

## Sources

- Official website: http://www.hisunpharm.com
- ClinicalTrials.gov: trials led by Zhejiang Hisun Pharmaceutical Co. Ltd.: https://clinicaltrials.gov/search?lead=Zhejiang%20Hisun%20Pharmaceutical%20Co.%20Ltd.
- Wikidata: https://www.wikidata.org/wiki/Q30260852

## Connected records

- terms: [Biosimilar](https://onco.cc/terms/biosimilar/), [Clinical trial](https://onco.cc/terms/clinical-trial/), [Pivotal (registrational) trial](https://onco.cc/terms/pivotal-trial/)

---
JSON: https://onco.cc/api/v1/entities/zhejiang-hisun.json